Aurobindo receives FDA nod for 3 generics The FDA has granted Aurobindo permission for generic Waylis, generic Noxafil and generic Olumiant. Generic drug makers continue forging ahead Generic drug companies continue to face obstacles, but there is no substitute for the solutions they are implementing to meet the needs of customers and patients. Avenacy debuts generic Aloxi Palonosetron hydrochloride injection is indicated as an antiemetic. FDA approves ForDoz's generic doxil liposome injection The drug is indicated for treatment of ovarian cancer, AIDS-related Kaposi’s Sarcoma and multiple myeloma. Samsung Bioepis obtains FDA nod for Soliris biosimilar Epysqli has been approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Meitheal Pharmaceuticals acquires Contepo from Nabriva Therapeutics Contepo is an intravenous broad-spectrum antibiotic for treating multi-drug resistant strains that cause urinary tract infections. Boehringer Ingelheim, GoodRx launch patient affordability initiative for Humira biosimilar Boehringer and GoodRx are offering the Humira biosimilar at a 92% discount from the Humira list price. Long Grove receives FDA nod for premix Vasopressin Vasopressin in sodium chloride injection is generally used to increase blood pressure when other measures have failed for patients in critical hypotensive shock. FDA gives Lupin tentative OK for generic Sutab Sodium sulfate, magnesium sulfate, and potassium chloride tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults. Biosimilars Council commends Senate passage of Cornyn-Blumenthal Patent Thicket legislation The Biosimilars Council encourages the House to take up this legislation and for Congress to continue working to help lower costs for patients. First Previous 15 16 17 18 19 Next Last
